Reports for PURDUE PHARMA
Company Name
PURDUE PHARMA
Totals |
||
Shortage reports |
140 |
|
| Actual shortage: | 0 (0%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (1%) | |
| Resolved: | 139 (99%) | |
Discontinuation Reports |
5 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 5 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
0 (0%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CODEINE CONTIN 50MG CONTROLLED RELEASE TAB | 50MG | TABLET (EXTENDED-RELEASE) | Avoided shortage | 2021-08-13 | 2021-08-24 | 144124 |
| MS.IR | 10MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2021-07-26 | 2021-12-10 | 143048 |
| MS.IR | 10MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2024-03-21 | 2024-03-28 | 222882 |
| MS CONTIN | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-11-10 | 2022-12-08 | 174235 |
| MS CONTIN | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-08-04 | 2021-10-02 | 143634 |
| MS CONTIN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-11-10 | 2022-12-08 | 174238 |
| MS.IR | 5MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2021-06-08 | 2021-07-16 | 140579 |
| MS.IR | 5MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2021-09-13 | 2021-10-08 | 145564 |
| MS.IR | 5MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2021-12-02 | 2021-12-22 | 150361 |
| MS.IR | 5MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2022-03-10 | 2022-05-18 | 156491 |
| MS.IR | 20MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2021-09-21 | 2021-12-18 | 145961 |
| MS.IR | 20MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2023-01-05 | 2023-01-24 | 179934 |
| MS.IR | 30MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2019-12-20 | 2020-03-23 | 101855 |
| MS.IR | 30MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2021-05-05 | 2021-05-29 | 138789 |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 3MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-01-25 | 2021-02-18 | 132378 |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 3MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-03-03 | 2021-03-16 | 135014 |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 3MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-04-23 | 2021-06-05 | 138032 |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 3MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-06-14 | 2021-07-06 | 140892 |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 3MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-07-09 | 2021-07-14 | 142283 |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 3MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-11-03 | 2021-11-30 | 148717 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DILAUDID | 1MG | Discontinued | 2018-03-01 | 2018-03-02 | 41479 | |
| BELBUCA | 75MCG | FILM, SOLUBLE | Discontinued | 2019-03-28 | 2019-04-02 | 79766 |
| BELBUCA | 150MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80230 |
| BELBUCA | 300MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80233 |
| BELBUCA | 450MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80236 |
Showing 1 to 5 of 5